Results 191 to 200 of about 4,450,920 (398)
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
A rough guide to the non‐coding RNA world of Salmonella [PDF]
Jörg Vogel
openalex +1 more source
Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
T. Yamano +12 more
semanticscholar +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Reviewer #1 (Public Review): Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos [PDF]
Pelea Oana +4 more
openalex +1 more source
A novel RNA-guided RNA-targeting CRISPR tool [PDF]
Zhang, Dandan +3 more
openaire +2 more sources
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Structure and engineering of Brevibacillus laterosporus Cas9
The RNA-guided DNA endonuclease Cas9 cleaves double-stranded DNA targets complementary to an RNA guide, and is widely used as a powerful genome-editing tool.
Toshihiro Nakane +9 more
doaj +1 more source
Unlocking the potential of CRISPR tools and databases for precision genome editing
Recent breakthroughs in CRISPR/Cas genome editing have transformed molecular biology research and offer significant potential across biotechnology and medicine.
Pooja Saraswat, Rajiv Ranjan
doaj +1 more source

